In the treatment model, compounds 5 and 6 also significantly attenuated the body weight gain, and the rise in fasting plasma glucose and insulin levels in the mice with pre-existing insulin resistance and obesity induced by 12-week HF feeding (see Figure S1 and Table S1). Here, INS is linked to obesity disorder.